Scarica l'app Stockscreener
0.785
0.76%
-0.006
Precedente Chiudi:
$0.791
Aprire:
$0.8
Volume 24 ore:
53,785
Relative Volume:
0.31
Capitalizzazione di mercato:
$4.08M
Reddito:
$35.52M
Utile/perdita netta:
$11.39M
Rapporto P/E:
-0.00994
EPS:
-78.9878
Flusso di cassa netto:
$-26.04M
1 W Prestazione:
-10.80%
1M Prestazione:
-23.79%
6M Prestazione:
-32.79%
1 anno Prestazione:
-55.57%
Intervallo 1D:
$0.78
$0.8049
Intervallo di 1 settimana:
$0.78
$0.93
Portata 52W:
$0.7101
$3.3099
Redhill Biopharma Ltd Adr Stock (RDHL) Company Profile
Compare RDHL vs TAK, HLN, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RDHL
Redhill Biopharma Ltd Adr
|
0.785 | 4.31M | 35.52M | 11.39M | -26.04M | -78.99 |
TAK
Takeda Pharmaceutical Co Adr
|
15.42 | 49.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.87 | 40.04B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.56 | 39.23B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
77.26 | 33.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
551.47 | 23.33B | 3.17B | 1.29B | 1.01B | 27.09 |
Redhill Biopharma Ltd Adr Stock (RDHL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-08-31 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-05-18 | Iniziato | H.C. Wainwright | Buy |
| 2020-09-11 | Iniziato | BTIG Research | Buy |
| 2019-07-12 | Aggiornamento | WBB Securities | Buy → Strong Buy |
| 2019-03-12 | Aggiornamento | WBB Securities | Speculative Buy → Buy |
| 2018-01-26 | Iniziato | Nomura | Buy |
| 2017-10-06 | Iniziato | Seaport Global Securities | Buy |
| 2017-10-04 | Reiterato | H.C. Wainwright | Buy |
| 2017-02-24 | Reiterato | FBR & Co. | Outperform |
| 2016-07-27 | Reiterato | FBR Capital | Outperform |
| 2015-09-29 | Iniziato | Nomura | Buy |
| 2015-07-29 | Reiterato | ROTH Capital | Buy |
| 2015-06-17 | Reiterato | H.C. Wainwright | Buy |
| 2015-06-15 | Reiterato | ROTH Capital | Buy |
Mostra tutto
Redhill Biopharma Ltd Adr Borsa (RDHL) Ultime notizie
Get insights into the top gainers and losers of Friday's after-hours session. - ChartMill
RedHill Biopharma begins Korea enforcement of $10.9M judgment By Investing.com - Investing.com South Africa
RedHill Biopharma begins Korea enforcement of $10.9M judgment - Investing.com
RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo - Sahm
RDHL News | REDHILL BIOPHARMA LTD-SP ADR (NASDAQ:RDHL) - ChartMill
RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms - Sahm
Redhill Biopharma stock soars on GLP-1 side effect treatment progress - Investing.com Nigeria
RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104Important Step in RHB-204 Development for MAP-related Crohn's Disease - ChartMill
RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights - Sahm
RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical StudiesNew Data Presented at AACR 2026 - ChartMill
RDHL Stock Price, Quote & Chart | REDHILL BIOPHARMA LTD-SP ADR (NASDAQ:RDHL) - ChartMill
RedHill Biopharma receives Nasdaq notice on minimum bid price requirement By Investing.com - Investing.com South Africa
RedHill Biopharma receives Nasdaq notice on minimum bid price requirement - Investing.com India
Adi Frish details equity holdings in RedHill Biopharma (RDHL) Form 3 - Stock Titan
RDHL Earnings History & Surprises | EPS & Revenue Results | REDHILL BIOPHARMA LTD-SP ADR (NASDAQ:RDHL) - ChartMill
Joint U.S. Commercialization of RedHill's Talicia® Commences - ChartMill
Joint U.S. Commercialization of RedHill's Talicia Commences - Finviz
RedHill Biopharma Calls March 5, 2026 Extraordinary Meeting to Approve RSU Grants and Share Capital Increase - The Globe and Mail
Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket - Benzinga
Redhill Biopharma stock soars on GLP-1 side effect treatment progress By Investing.com - Investing.com South Africa
RedHill advances once-daily ondansetron tablet for GLP-1 side effects - Investing.com
RedHill advances once-daily ondansetron tablet for GLP-1 side effects By Investing.com - Investing.com India
RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects - Finviz
RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells - Sahm
CapEx per share of RedHill Biopharma Ltd. Sponsored ADR – FWB:2RH - TradingView — Track All Markets
RedHill Biopharma regains compliance with Nasdaq listing requirements - Investing.com
RedHill Biopharma increases maximum amount for at-the-market ADS offering - Investing.com
Redhill Biopharma stock jumps after court win against Kukbo By Investing.com - Investing.com Canada
RedHill Biopharma to appeal Nasdaq compliance notice - Investing.com
Cumberland invests $4 million for 30% stake in RedHill’s Talicia business By Investing.com - Investing.com
RedHill Biopharma Signs New $1.8 Million Plus Sales Royalties Middle East Deal For Talicia - Finviz
Redhill Biopharma Ltd. (RDHL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Wondering what's happening in today's pre-market session? - ChartMill
RedHill Biopharma receives Nasdaq extension to regain compliance by October - Investing.com
Get insights into the top gainers and losers of Monday's after-hours session. - ChartMill
RedHill Biopharma Secures Kukbo Asset Freeze Following RedHill's $8.25 Million Plus Legal Fees New York Supreme Court Summary Judgment Win - Finviz
RedHill Biopharma Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency - PR Newswire
Redhill Biopharma stock hits 52-week low at $2.47 amid steep annual decline - Investing.com
Redhill Biopharma stock hits 52-week low at $3 amid steep annual decline - Investing.com UK
Redhill Biopharma Ltd Share Price ADR Each Representing 1000 Ord Shares SPON - Hargreaves Lansdown
7 Undervalued Pharmaceuticals Stocks for Wednesday, August 07 - AAII
Trading Volume Is Your Friend - StocksToTrade
Curious about the stocks that are showing activity after the closing bell on Tuesday? - ChartMill
Opaganib eyed for Sulfur Mustard countermeasure By Investing.com - Investing.com South Africa
Wednesday's session: gap up and gap down stocks - ChartMill
Stay updated with the stocks that are on the move in today's after-hours session. - ChartMill
Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps. - ChartMill
symbol__ Stock Quote Price and Forecast - CNN
Discover the top movers in Monday's pre-market session and stay informed about market dynamics. - ChartMill
Get insights into the top gainers and losers of Monday's pre-market session. - ChartMill
RedHill Biopharma Announces Talicia Approved in the United Arab Emirates and First Commercial Order Outside the U.S. - Barchart
Redhill Biopharma Ltd Adr Azioni (RDHL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.95%
1.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):